Status:
COMPLETED
COVID-19: Post-covid Olfactory Disorders Assessment
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Olfaction Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Covid 19 cause an olfactory loss in more than 80% of cases. This loss most often regresses but leaves 20% of patients with an olfactory complaint, particularly with regard to the quality of daily life...
Eligibility Criteria
Inclusion
- Adults patient,
- anosmia during a COVID19 acute infection (PCR+) and persistant olfactive disoders at least 6 weeks after symptoms disappeared.
Exclusion
- preexisting smell loss.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04799977
Start Date
October 1 2020
End Date
April 1 2021
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUFC
Nice, France, 06100